Jayanti Das , Adam C Fisher , Lisa Hughey , Thomas F O’Connor , Vidya Pai , Cinque Soto , John Wan
{"title":"Considerations for Big Data management in pharmaceutical manufacturing","authors":"Jayanti Das , Adam C Fisher , Lisa Hughey , Thomas F O’Connor , Vidya Pai , Cinque Soto , John Wan","doi":"10.1016/j.coche.2024.101051","DOIUrl":null,"url":null,"abstract":"<div><div>Big Data technologies are advancing the manufacturing of drug and biological products. Such technologies include innovative software and computational methods for data storage, mining, and analytics. Increasingly vast, complex data sets are being produced by advanced manufacturing processes and sensors for statistical analysis and decision-making. Implementing Big Data technologies, however, can introduce new challenges for organizations in areas of data generation, architecture, and security. Big Data management includes implementing robust storage, complex data integration, and state-of-the-art analysis software. Upholding data integrity and security might require designing a modernized risk-based framework plan for the organization. Once these challenges are successfully addressed, the incorporation of Big Data technologies into pharmaceutical manufacturing is expected to enable more efficient production, lower costs, and greater quality control, resulting in a stronger global pharmaceutical supply chain.</div></div>","PeriodicalId":292,"journal":{"name":"Current Opinion in Chemical Engineering","volume":"46 ","pages":"Article 101051"},"PeriodicalIF":8.0000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Chemical Engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211339824000522","RegionNum":2,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Big Data technologies are advancing the manufacturing of drug and biological products. Such technologies include innovative software and computational methods for data storage, mining, and analytics. Increasingly vast, complex data sets are being produced by advanced manufacturing processes and sensors for statistical analysis and decision-making. Implementing Big Data technologies, however, can introduce new challenges for organizations in areas of data generation, architecture, and security. Big Data management includes implementing robust storage, complex data integration, and state-of-the-art analysis software. Upholding data integrity and security might require designing a modernized risk-based framework plan for the organization. Once these challenges are successfully addressed, the incorporation of Big Data technologies into pharmaceutical manufacturing is expected to enable more efficient production, lower costs, and greater quality control, resulting in a stronger global pharmaceutical supply chain.
期刊介绍:
Current Opinion in Chemical Engineering is devoted to bringing forth short and focused review articles written by experts on current advances in different areas of chemical engineering. Only invited review articles will be published.
The goals of each review article in Current Opinion in Chemical Engineering are:
1. To acquaint the reader/researcher with the most important recent papers in the given topic.
2. To provide the reader with the views/opinions of the expert in each topic.
The reviews are short (about 2500 words or 5-10 printed pages with figures) and serve as an invaluable source of information for researchers, teachers, professionals and students. The reviews also aim to stimulate exchange of ideas among experts.
Themed sections:
Each review will focus on particular aspects of one of the following themed sections of chemical engineering:
1. Nanotechnology
2. Energy and environmental engineering
3. Biotechnology and bioprocess engineering
4. Biological engineering (covering tissue engineering, regenerative medicine, drug delivery)
5. Separation engineering (covering membrane technologies, adsorbents, desalination, distillation etc.)
6. Materials engineering (covering biomaterials, inorganic especially ceramic materials, nanostructured materials).
7. Process systems engineering
8. Reaction engineering and catalysis.